[Infections risk in transrectal prostate biopsy. An experience of antibioprophylaxis at a single dose].
Prostate biopsy remains the key-test in diagnosing clinically-detected prostatic carcinoma. Easy and efficient, the transrectal approach is credited with major infectious risk. The authors report a conclusive clinical experiment on 180 cases with antibioprophylaxy by injecting a single dose of third generation cephalosporin.
Houdelette
P
P
Service de Chirurgie Urologique, HIA Sainte-Anne, Toulon, Naval.
Dumotier
J
J
Peyrottes
A
A
Pierre
C
C
D000368:Aged; D000369:Aged, 80 and over; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001424:Bacterial Infections / Q000209:etiology / Q000517:prevention & control*; D001707:Biopsy, Needle / Q000009:adverse effects*; D002443:Ceftriaxone / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008875:Middle Aged; D011471:Prostatic Neoplasms / Q000175:diagnosis
D000900:Anti-Bacterial Agents; D002443:Ceftriaxone